Back to Results
First PageMeta Content
Pharmacology / Organofluorides / Bristol-Myers Squibb / Gilead Sciences / Carbamates / Antiretroviral drug / Efavirenz / Darunavir / Tenofovir/emtricitabine / Chemistry / Organic chemistry / Protease inhibitors


Microsoft Word - A_25[1].doc
Add to Reading List

Open Document

File Size: 89,29 KB

Share Result on Facebook

City

Chiang Mai / Baltimore / Bristol / /

Company

GlaxoSmithKline / Prevention Needlestick Surveillance Group / Tibotec Therapeutics / Monogram Biosciences / Abbott Laboratories / Meyers Squibb / AIDS Clinical Trials Group / Medical Management / /

Continent

Africa / /

Country

Thailand / United States / South Africa / /

IndustryTerm

healthcare workers / treatment of HIV / HIV Prevention / pre-or post-travel quandary / web-based educational tool / pre-travel preparation / pre-travel consultation / /

MedicalCondition

HIV infection / HIV / advanced HIV disease / HIV seroconversion / AIDS / /

MedicalTreatment

antiretroviral therapy / /

Organization

Advisory Board of Pfizer / Merck / Bristol‐Meyers Squibb / Gilead Sciences / and Tibotec Therapeutics / Division of Infectious Diseases / Updated U.S. Public Health Service / Johns Hopkins Bloomberg School of Public Health / DHHS Panel for Antiretroviral Guidelines for Adults and Adolescents / Centers for Disease Control and Prevention / the Johns Hopkins University School of Medicine / /

Person

Interest Joel Gallant / Joel E. Gallant / /

Position

investigator / author / editor-in-chief / Director of the Johns Hopkins AIDS Service / Professor of Epidemiology / co-author / Professor of Medicine / member / /

Product

efavirenz / zidovudine / nevirapine / abacavir / lamivudine / didanosine / stavudine / /

PublishedMedium

the Johns Hopkins HIV Guide / /

Region

Saharan Africa / /

SocialTag